Silent nephritis in systemic lupus erythematosus

Area of Science:

• Nephrology
• Rheumatology
• Immunology

Background:

• Systemic lupus erythematosus (SLE) frequently involves the kidneys.
• Distinguishing between silent lupus nephritis (SLN) and overt lupus nephropathy (OLN) is crucial for patient management.
• Renal biopsy remains the gold standard for diagnosing lupus nephritis.

Purpose of the Study:

• To investigate the prevalence and characteristics of SLN in renal asymptomatic SLE patients.
• To compare SLN with OLN in terms of clinical, serological, and histopathological findings.
• To identify potential biomarkers for early detection of renal involvement in SLE.

Main Methods:

• Prospective study comparing 42 renal asymptomatic patients with SLN and 49 untreated patients with OLN.
• Evaluation of urinary sediment, quantitative proteinuria, creatinine clearance, antinuclear antibodies (ANA), complement levels (C3, C4, CH50), circulating immune complexes (CIC), and renal biopsies.
• Histopathological classification of lupus nephritis according to WHO criteria.

Main Results:

• SLN was detected in 97.6% of renal asymptomatic SLE patients.
• No significant differences in age, sex, SLEDAI, ANA, anti-ds DNA, anti-ENA, or C4 levels between SLN and OLN groups.
• Elevated CIC and diminished CH50 and C3 levels were significantly associated with OLN (P < 0.01).
• WHO class II lesions predominated in SLN (P < 0.0001), while class IV lesions were more common in OLN (P < 0.0001).

Conclusions:

• SLN is highly prevalent in renal asymptomatic SLE patients.
• Abnormal CIC, CH50, and C3 levels, coupled with WHO class II lesions, suggest moderate, ongoing immune-mediated renal injury in SLN.
• These findings highlight the importance of vigilant monitoring for renal involvement even in asymptomatic SLE patients.